Psychiatric University Clinics (UPK) Basel, Basel, Switzerland.
Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
Neurosci Biobehav Rev. 2016 Dec;71:680-690. doi: 10.1016/j.neubiorev.2016.10.007. Epub 2016 Oct 20.
Several magnetic resonance imaging studies have reported reductions in hippocampal volume in patients with psychosis. It is unclear whether structural abnormalities predate illness onset. We conducted a detailed, systematic literature search for studies reporting hippocampal volume in subjects with clinical high-risk, compared to healthy controls. The overall sample size comprised 1429 subjects. Meta-analysis revealed no difference for left, but a small, albeit significant, difference for right hippocampal volume, such that clinical high-risk patients had slightly smaller hippocampal volume than healthy controls (g=0.24, p=0.0418). Meta-regression indicated a moderating effect of manual tracing approach, due to one outlying site. The small difference on the right side did not remain significant (g=0.14, 95%CI=[-0.03-0.32], p=0.11) after removal of this outlier. This meta-analysis suggests that there is no reduction in hippocampal volume before transition to psychosis and hippocampal volume cannot be used as a biomarker in clinical high-risk individuals.
几项磁共振成像研究报告称,精神病患者的海马体体积减小。目前尚不清楚结构异常是否先于疾病发作。我们对报告临床高风险人群与健康对照组海马体体积的研究进行了详细的系统文献检索。总体样本量包括 1429 名受试者。荟萃分析显示,左侧海马体体积没有差异,但右侧海马体体积存在微小但显著的差异,即临床高风险患者的海马体体积比健康对照组略小(g=0.24,p=0.0418)。元回归表明,由于一个异常部位,手动追踪方法存在调节作用。去除该异常值后,右侧的微小差异不再显著(g=0.14,95%CI=[-0.03-0.32],p=0.11)。这项荟萃分析表明,在向精神病过渡之前,海马体体积没有减少,并且海马体体积不能作为临床高风险个体的生物标志物。